A clinical report and further delineation of the 14q32 deletion syndrome

Clinical Dysmorphology

Volumn 20, Issue 3, 2011, Pages 143-147

  Youngs, Erin L ^a   Hellings, Jessica A ^a   Butler, Merlin G ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE DEVELOPMENT; MICROARRAY ANALYSIS; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PRIORITY JOURNAL;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; HUMANS; INFANT; PHENOTYPE; SYNDROME;

EID: 79959243529     PISSN: 09628827     EISSN: 14735717     Source Type: Journal    
DOI: 10.1097/MCD.0b013e3283438200     Document Type: Article

References (15)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington DC: American Psychiatric Association. pp. 1-943.
2. Deng Y, Madan A, Banta AB, Friedman C, Trask BJ, Hood L, Li L (2000). Characterization, chromosomal localization, and the complete 30-kb DNA sequence of the human Jagged2 (JAG2) gene. Genomics 63:133-138. (Pubitemid 30112247)
3. Hreidarsson SJ, Stamberg J (1983). Distal monosomy 14 not associated with ring formation. J Med Genet 20:147-148.
4. Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ, Thorarinsdottir TE, et al. (2004). BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron 44:931-945. (Pubitemid 39643090)
5. Klein SC, Haas RC, Perryman MB, Billadello JJ, Strauss AW (1991). Regulatory element analysis and structural characterization of the human sarcomeric mitochondrial creatine kinase gene. J Biol Chem 266:18058-18065. (Pubitemid 21908047)
6. Masada CT, Olney AH, Fordyce R, Sanger WG (1989). Partial deletion of 14q and partial duplication of 14q in sibs: testicular mosaicism for t(14q;14q) as a common mechanism. Am J Med Genet 34:635-637.
7. Maurin ML, Brisset S, Le Lorc?h M, Trioche P, Aboura A, Labrune P, Tachdjian G (2006). Terminal 14q32.33 deletion: genotype-phenotype correlation. Am J Med Genet 140A:2324-2329. (Pubitemid 44684959)
8. Ortigas AP, Stein CK, Thomson L, Hoo JJ (1997). Delineation of 14q32.3 deletion syndrome. J Med Genet 34:515-517. (Pubitemid 27268135)
9. Schlade-Bartusiak K, Costa T, Summers AM, Nowaczyk MJM, Cox DW (2005). FISH mapping of telomeric 14q32 deletions: search for the cause of seizures. Am J Med Genet 138A:218-224. (Pubitemid 41384236)
10. Schlade-Bartusiak K, Ardinger H, Cox DW (2009). A child with terminal 14q deletion syndrome: consideration of genotype-phenotype correlations. Am J Med Genet 149A:1012-1018.
11. Teleford N, Thompson DAG, Griffiths MJ, Ilett S,Watt JL (1990). Terminal deletion (14) (q32.3): a new case. J Med Genet 27:261-263.
12. Van Karnebeek CD, Quik S, Sluijter S, Hulsbeek MMF, Hoovers JMN, Hennekam RCM (2002). Further delineation of the chromosome 14q terminal deletion syndrome. Am J Med Genet 110:65-72. (Pubitemid 34507323)
13. Wang HS, Allanson JE (1992). A further case of terminal deletion (14)(q32.2) in a child with mild dysmorphic features. Ann Genet 35:171-173. (Pubitemid 23009271)
14. Wintle RG, Costa MT, Haslam RHA, Teshima IE, Cox DW (1995). Molecular analysis redefines three human chromosome 14 deletions. Hum Genet 95:495-500.
15. Zollino M, Seminara L, Orteschi D, Gobbi G, Giovannini S, Della Giustina E, et al. (2009). The ring 14 syndrome: clinical and molecular definition. Am J Med Genet 149A:1116-1124.